Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer

NCT06595498 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-small Cell Lung Cancer (NSCLC)

Interventions

DIAGNOSTIC_TEST: Plasma- SeqSensei™ Solid Cancer IVD Kit (Sysmex)
DIAGNOSTIC_TEST: cobas® EGFR Mutation Test v2 (Roche)

Sponsor

Istituto Oncologico Veneto IRCCS